Tryptamine Therapeutics Limited
TYPTF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.81% | 650.21% | 863.04% | 146.84% | -80.84% |
| Total Receivables | 2,342.02% | 4,380.28% | 131.82% | 561.11% | 344.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,141.64% | 833.17% | -80.89% | -79.70% | -81.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -50.17% | -58.71% | -47.91% |
| Total Current Assets | 85.56% | 838.77% | 58.01% | 98.07% | -78.61% |
|
|
|||||
| Total Current Assets | 85.56% | 838.77% | 58.01% | 98.07% | -78.61% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 74.41% | 94.94% | 5.25% | 4.73% | 1.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 89.07% | 661.09% | 40.84% | 86.00% | -73.03% |
|
|
|||||
| Total Accounts Payable | -59.78% | -54.01% | -47.27% | 27.12% | 58.17% |
| Total Accrued Expenses | 139.21% | -8.56% | -28.21% | -45.30% | 87.61% |
| Short-term Debt | -99.17% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -87.23% | -49.56% | 221.01% | 343.62% | 59.32% |
|
|
|||||
| Total Current Liabilities | -87.23% | -49.56% | 221.01% | 343.62% | 59.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -99.17% | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -87.72% | -77.47% | 231.08% | 361.21% | 256.67% |
|
|
|||||
| Common Stock & APIC | 59.92% | 78.99% | 0.97% | 0.95% | -1.30% |
| Retained Earnings | -26.73% | -49.28% | -23.85% | -26.58% | -28.06% |
| Treasury Stock & Other | 652.55% | 740.88% | 0.25% | -0.27% | -3.39% |
| Total Common Equity | 172.72% | 205.73% | -295.22% | -1,498.58% | -417.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 172.72% | 205.73% | -295.22% | -1,498.58% | -417.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 172.72% | 205.73% | -295.22% | -1,498.58% | -417.73% |
|
|
|||||
